Multidisciplinary Management of a Rare Case of Esophageal Adenocarcinoma with Cardiac, Pulmonary, Liver, Adrenal Gland and Brain Metastasis

2016 ◽  
Vol 02 (01) ◽  
Author(s):  
Tingrui Wang ◽  
Zonghui Ding ◽  
Sabyasachi Roy ◽  
Richard Manch ◽  
Jue Wang
Author(s):  
Tarun Chaudhary ◽  
Shikhar Agrawal ◽  
Manoj Biswas ◽  
Rajeev Sarpal ◽  
Nadia Shirazi

2013 ◽  
Vol 74 (11) ◽  
pp. 3201-3205
Author(s):  
Masahiro SHIBATA ◽  
Yatsuka HIBI ◽  
Kimio OGAWA ◽  
Yoshimi SHIMIZU ◽  
Chikara KAGAWA ◽  
...  

2017 ◽  
Vol 07 (02) ◽  
pp. 164-167
Author(s):  
Hanish Bansal ◽  
Ashwani Chaudhary ◽  
Dipesh Batra ◽  
Rohit Jindal

AbstractWe report a very rare case of a 63-year-old man with penile carcinoma who developed brain metastasis. Brain metastasis from penile carcinoma is very rare, and only six cases have been reported so far as per our literature review. In view of controlled primary tumor and absence of systemic disease, tumor was excised and the patient remained clinically controlled till 3 months after follow-up.


2018 ◽  
Vol 149 (suppl_1) ◽  
pp. S103-S103
Author(s):  
Sonia Veran-Taguibao ◽  
Roberto Alvaro Taguibao ◽  
Ted Farzaneh ◽  
Di Lu

2019 ◽  
Vol 10 (1) ◽  
pp. 73-75
Author(s):  
Israt Rezwana ◽  
Sourav Sarkar ◽  
Rushda Sharmin Binte Rouf ◽  
Sultana Marufa Shefin ◽  
SM Ashrafuzzaman

Adrenal sarcomatoid carcinoma (ASC) are very rare and aggressive malignant tumors of adrenal glands containing both epithelial (carcinomatous) and mesenchymal (sarcomatous) components. ASC presents a diagnostic challenge due to its atypical symptoms and histological patterns which influence treatment.At the time of diagnosis, a large percentage of patients are already at the metastatic stage and succumb within a few months. Here, we report a case of functional sarcomatoid carcinoma in right adrenal gland in a 37-year-old female, who presented with new onset hypertension. The patient underwent right sided adrenalectomy and she was alive at the time of writing the current report.To the best of our knowledge, ASC reported in literature to date showed only few patient presented with endocrine hypersecretion and only one patient presented with both hypertension and endocrine dysfunction. So, our case is the rarest among the rare. Birdem Med J 2020; 10(1): 73-75


2019 ◽  
Vol 7 ◽  
pp. 232470961989210
Author(s):  
Hardik S. Chhatrala ◽  
John Khuu ◽  
Lara Zuberi

Metachronous contralateral breast cancer (MCBC) is defined as contralateral breast cancer (BC) diagnosed more than 1 year after previous BC diagnosis. More BC survivors are at risk of MCBC given improved life expectancy with the availability of advanced cancer care. Estrogen receptor/progesterone receptor negative and HER-2-positive status of first BC are independent risk factors for the development of MCBC. We present a rare case of triple positive (estrogen receptor, progesterone receptor, HER-2 positive) MCBC patient who eventually developed brain metastasis within 15 months despite a near complete pathologic response of primary tumor. This case highlights that even in this era of antiestrogen and anti-HER-2 therapies, triple positive MCBC can have an aggressive clinical course, especially with brain metastasis as the first sign of metastasis.


2020 ◽  
Vol 4 (Supplement_1) ◽  
Author(s):  
David Joseph Tansey ◽  
Mensud Hatunic ◽  
John Conneely ◽  
Michelle Murray

Abstract Background: Pheochromocytoma is a rare catecholamine-producing tumor with an estimated incidence of less than 0.1% in the global population. We present the case of a pheochromocytoma in a 25-year-old man with a background history of a double-lung transplant for Cystic Fibrosis, carried out 5 years earlier. Clinical Case: A 25 year old, with a background history of Cystic Fibrosis and a Double Lung transplant in 2012 presented to the emergency department with crampy abdominal pain, nausea and vomiting. He was diagnosed with Distal Intestinal Obstruction syndrome (DIOS) for which he was admitted for rehydration and laxatives. Contrast-enhanced computed tomography (CT) imaging of the abdomen and pelvis which showed a 3.4 cm right adrenal lesion, which was confirmed by a subsequent MRI Adrenals and an Endocrinology review was requested. On review, the patient was noted to be hypertensive with a blood pressure averaging 170/90 despite treatment with 3 different anti-hypertensive medications - namely amlodipine, telmisartan and doxazosin. On review of his medical notes, it was clear that he had been persistently hypertensive over the last 3 years. On further questioning, he noted increasingly frequent sweating episodes over the last number of months but denied any palpitations, headache or back pain. Laboratory analysis showed an elevated plasma normetanephrines (NMN) of 3167 pmol/L (182-867) as well as elevated metanephrines (MN) of 793 pmol/L (61-377) and high 3-MT of 257 pmol/L (<185). His MIBG scan showed only a mild increase in the uptake of tracer to the right adrenal gland compared to the left. The case was discussed at a multidisciplinary meeting and given the suggestive laboratory and radiologic findings, a presumptive diagnosis of pheochromocytoma was made. After controlling blood pressure with an alpha-blocker and beta-blocker for a week, the patient was hydrated and scheduled for an elective right adrenalectomy. The histopathology of the excised adrenal gland was consistent with a 3cm pheochromocytoma with none of the adverse features associated with malignant potential. The patient recovered well post-op, his blood pressure normalised and he was discharged home well for follow-up at the Endocrine and Transplant clinics. Conclusion: We describe a rare case of a right adrenal pheochromocytoma in a young man with multiple co-morbidities, who completely recovered after tumor resection. This case highlights the crucial importance of investigating secondary causes of hypertension, especially in younger patients. This is the first documented case in the literature of a case of pheochromocytoma in a post-transplant patient with Cystic Fibrosis. References: 1. Farrugia FA, Marikos G et al. Pheochromocytoma, diagnosis and treatment: Review of the literature. Endocrine Regulation, Volume 51, Issue 3, 30th August 2017.


Sign in / Sign up

Export Citation Format

Share Document